Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Unlock member only benefits by creating a free account and get more deals, bigger discounts, and access to more articles
Studies have consistently shown that tirzepatide can provide more weight loss than single-agonist GLP-1 drugs like semaglutide (Ozempic and Wegovy), ranging around 20% lost weight over a years time on average
[1] In 2024, global spend on anti-obesity medication exceeded $30 billion for the first time, which is over a ten-fold increase since 2020, as reported by IQVIA
Brand-Name Costs (Without Insurance): Monthly List Prices: Wegovy (semaglutide): $1,349 Ozempic (semaglutide): $969 Zepbound (tirzepatide): $1,069 Mounjaro (tirzepatide): $1,069 Saxenda (liraglutide): $1,400 Annual Costs: Semaglutide: $11,628-$16,188/year Tirzepatide: $12,828/year For 18-month treatment: $17,442-$24,282 These prices are unsustainable for most cash-pay patients
The effect of rate of weight loss on long-term weight management: a randomised controlled trial
Results differ from person to person
US$ 29.58
US$ 21.75
US$ 25.10
US$ 27.54
US$ 27.92
US$ 29.68
US$ 21.26
